Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?
Arcturus Therapeutics Ownership Summary
Arcturus Therapeutics is owned by 97.02% institutional investors, 8.46% insiders. Sumitomo mitsui trust is the largest institutional shareholder, holding 7.63% of ARCT shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 8.99% of its assets in Arcturus Therapeutics shares.
ARCT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Arcturus Therapeutics | 97.02% | 8.46% | -5.48% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Sumitomo mitsui trust | 2.07M | 7.63% | $35.04B |
Ark investment management | 1.93M | 7.15% | $32.82M |
Empire life investments | 279.46K | 1.03% | $4.74M |
Hennion & walsh asset management | 82.06K | 0.30% | $1.39M |
Bank of new york mellon | 78.18K | 0.29% | $1.33M |
Nordea investment management ab | 65.78K | 0.24% | $1.10M |
Dekabank deutsche girozentrale | 43.89K | 0.16% | $1.08M |
Rhumbline advisers | 33.04K | 0.12% | $560.74K |
Tritonpoint wealth | 28.07K | 0.10% | $476.39K |
Los angeles capital management | 23.81K | 0.09% | $404.02K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Empire life investments | 279.46K | 0.30% | $4.74M |
Ark investment management | 1.93M | 0.27% | $32.82M |
Hennion & walsh asset management | 82.06K | 0.06% | $1.39M |
Tritonpoint wealth | 28.07K | 0.04% | $476.39K |
Sumitomo mitsui trust | 2.07M | 0.02% | $35.04B |
Byrne asset management | 1.52K | 0.02% | $25.79K |
China universal asset management | 5.74K | 0.01% | $97.48K |
Spire wealth management | 13.48K | 0.01% | $228.72K |
Dekabank deutsche girozentrale | 43.89K | 0.00% | $1.08M |
Los angeles capital management | 23.81K | 0.00% | $404.02K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Empire life investments | 279.46K | 0.30% | 128.77K |
Hennion & walsh asset management | 82.06K | 0.06% | 47.82K |
Spire wealth management | 13.48K | 0.01% | 10.75K |
Nordea investment management ab | 65.78K | 0.00% | 2.33K |
China universal asset management | 5.74K | 0.01% | 543.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sumitomo mitsui trust | 2.07M | 0.02% | -210.66K |
Ark investment management | 1.93M | 0.27% | -167.19K |
Harbor capital advisors | - | - | -42.63K |
Vontobel | - | - | -29.73K |
Bank of new york mellon | 78.18K | 0.00% | -22.02K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Skopos labs | 288.00 | 0.00% | 288.00 | $4.89K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -2.00 |
Gps wealth strategies group | -10.00 |
Davenport | -15.90K |
Banque pictet & cie sa | -20.00K |
Vontobel | -29.73K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 170 | -4.49% | 26,254,877 | -0.08% | 97 | 1.02% | 81 | 5.19% | 49 | -27.94% |
Jun 30, 2024 | 178 | -5.82% | 26,276,502 | -3.48% | 97 | 0.95% | 77 | -15.38% | 68 | 11.48% |
Mar 31, 2024 | 189 | 9.25% | 27,224,704 | 7.13% | 101 | 1.11% | 91 | - | 61 | 15.09% |
Dec 31, 2023 | 173 | 11.61% | 25,412,469 | 1.02% | 95 | 1.06% | 91 | 26.39% | 53 | -1.85% |
Sep 30, 2023 | 155 | 4.73% | 25,156,306 | 6.49% | 94 | 1.20% | 72 | -1.37% | 54 | 3.85% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Federated Hermes Kaufmann Growth | 2.44M | 8.99% | - |
Federated Hermes Kaufmann R | 2.44M | 8.99% | - |
Federated Hermes Kaufmann Small Cap A | 2.20M | 8.11% | - |
Federated Hermes Kaufmann Small Cap Grow | 2.20M | 8.11% | - |
ARK Genomic Revolution ETF | 1.92M | 7.08% | - |
ARK Genomic Revolution | 1.91M | 7.05% | -177.95K |
Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.80M | 6.66% | -77.08K |
Vanguard Total Stock Mkt Idx Inv | 724.72K | 2.68% | - |
iShares Russell 2000 ETF | 628.55K | 2.32% | -95.00 |
SPDR® S&P Biotech ETF | 627.26K | 2.32% | -2.32K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $249.12K |
Jun 12, 2024 | SASSINE ANDY | Chief Financial Officer | Sell | $1.60M |
Jun 05, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $5.13K |
Jun 03, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $1.04M |
Mar 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $610.57K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 1 |
2024 Q2 | - | 3 |
2024 Q1 | - | 2 |
2023 Q4 | - | 2 |
2023 Q3 | - | 5 |
ARCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools